ABBOTT LABORATORIES — Director's Dealing 2015

Feb 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2015-02-20

Reporting Person: Landgraf John C (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-20	Common shares without par value	A	23457	—	Acquired	120502	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-20	Option (right to buy)	$47.00	A	165292	Acquired	2025-02-19	Common shares (165292)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	18963	Indirect
Common shares without par value	171	Indirect

Footnotes

F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 20, 2015.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.

F4: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 55,098 on 2/20/16, 55,097 on 2/20/17, and 55,097 on 2/20/18.